Sparse Learner Boosting for Gene Expression Data
نویسندگان
چکیده
منابع مشابه
Boosting for Tumor Classification with Gene Expression Data
MOTIVATION Microarray experiments generate large datasets with expression values for thousands of genes but not more than a few dozens of samples. Accurate supervised classification of tissue samples in such high-dimensional problems is difficult but often crucial for successful diagnosis and treatment. A promising way to meet this challenge is by using boosting in conjunction with decision tre...
متن کاملGene Identification from Microarray Data for Diagnosis of Acute Myeloid and Lymphoblastic Leukemia Using a Sparse Gene Selection Method
Background: Microarray experiments can simultaneously determine the expression of thousands of genes. Identification of potential genes from microarray data for diagnosis of cancer is important. This study aimed to identify genes for the diagnosis of acute myeloid and lymphoblastic leukemia using a sparse feature selection method. Materials and Methods: In this descriptive study, the expressio...
متن کاملSparse Matrix Factorization of Gene Expression Data
Motivation: Gene expression data consists of expression level reads for thousands of genes across dozens of experimental conditions, time points, cell types or repeated experiments. The goal of unsupervised modeling of such data is to find some underlying organization, structure or redundancy in the data, such as similarity or dependency between genes or between experiments. Such structure can ...
متن کاملSparse Boosting
We propose Sparse Boosting (the SparseL2Boost algorithm), a variant on boosting with the squared error loss. SparseL2Boost yields sparser solutions than the previously proposed L2Boosting by minimizing some penalized L2-loss functions, the FPE model selection criteria, through smallstep gradient descent. Although boosting may give already relatively sparse solutions, for example corresponding t...
متن کاملSparse Representation for Classification of Tumors Using Gene Expression Data
Personalized drug design requires the classification of cancer patients as accurate as possible. With advances in genome sequencing and microarray technology, a large amount of gene expression data has been and will continuously be produced from various cancerous patients. Such cancer-alerted gene expression data allows us to classify tumors at the genomewide level. However, cancer-alerted gene...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: IPSJ Transactions on Bioinformatics
سال: 2010
ISSN: 1882-6679
DOI: 10.2197/ipsjtbio.3.54